References
www.ginasthma.org
1. Global INitiative for Asthma, global strategy for asthma management and prevention, 2023. Updated July 2023. Available from: . 2023.2. Alizadeh Bahmani AH, Abdel-Aziz MI, Maitland-van der Zee AH, Vijverberg SJH. Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective. Expert Rev Clin Pharmacol. 2022;15(10):1165-1176.3. Beeh KM, Kuna P, Corradi M, Viaud I, Guasconi A, Georges G. Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial. Int J Chron Obstruct Pulmon Dis. 2021;16:79-89.4. Usmani OS. Choosing the right inhaler for your asthma or COPD patient. Ther Clin Risk Manag. 2019;15:461-472.5. Momeni S, Nokhodchi A, Ghanbarzadeh S, Hamishehkar H. The Effect of Spacer Morphology on the Aerosolization Performance of Metered-Dose Inhalers. Adv Pharm Bull. 2016;6(2):257-260.6. Ding B, Small M, Scheffel G, Holmgren U. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927-936.7. Ramadan WH, Sarkis AT. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study.Chron Respir Dis. 2017;14(3):309-320.8. Sullivan A, Hunt E, MacSharry J, Murphy DM. ’The Microbiome and the Pathophysiology of Asthma’. Respir Res. 2016;17(1):163.9. Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17(5):592-602.10. Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduction and Targeted Therapy. 2024;9(1):19.11. Belstrøm D, Holmstrup P, Bardow A, Kokaras A, Fiehn NE, Paster BJ. Comparative analysis of bacterial profiles in unstimulated and stimulated saliva samples. J Oral Microbiol. 2016;8:30112.12. Hartmann JE, Albrich WC, Dmitrijeva M, Kahlert CR. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review.Front Med (Lausanne). 2021;8:588584.13. Huang C, Ni Y, Du W, Shi G. Effect of inhaled corticosteroids on microbiome and microbial correlations in asthma over a 9-month period. Clin Transl Sci. 2022;15(7):1723-1736.14. Heffler E, Madeira LNG, Ferrando M, et al. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. J Allergy Clin Immunol Pract. 2018;6(3):776-781.15. Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;2012(7):Cd002991.16. Galván CA, Guarderas JC. Practical considerations for dysphonia caused by inhaled corticosteroids.Mayo Clin Proc. 2012;87(9):901-904.17. Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol. 2007;98(3):225-238.18. Abdel-Aziz MI, Neerincx AH, Vijverberg SJH, et al. A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric Asthma. J Pers Med. 2021;11(6).19. Alizadeh Bahmani AH, Slob EMA, Bloemsma LD, et al. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study. Eur J Pharm Sci. 2023;181:106360.20. Blankestijn JM, Lopez-Rincon A, Neerincx AH, et al. Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma. Pediatr Allergy Immunol. 2023;34(2):e13919.21. Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047-3048.22. S A. FastQC: A Quality Control Tool for High Throughput Sequence Data. 2010 [cited 2022 January 10th].23. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:10-12.24. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581-583.25. Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590-596.26. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217.27. Oksanen J, Blanchet FG, Kindt R, et al. Community ecology package. R package version. 2013;2(0):321-326.28. Lin H, Peddada SD. Analysis of compositions of microbiomes with bias correction. Nature communications. 2020;11(1):3514.29. Sharma D, Paterson AD, Xu W. TaxoNN: ensemble of neural networks on stratified microbiome data for disease prediction. Bioinformatics. 2020;36(17):4544-4550.30. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817-825.31. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65.32. Elander A, Gustafsson M. Inhaler Technique and Self-reported Adherence to Medications Among Hospitalised People with Asthma and COPD. Drugs Real World Outcomes. 2020;7(4):317-323.33. Karched M, Bhardwaj RG, Asikainen SE. Coaggregation and biofilm growth of Granulicatella spp. with Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans.BMC Microbiology. 2015;15(1):114.34. Aabed K, Moubayed N, Ramadan RS, BinShabaib MS, Alharthi SS. A population-based study of the salivary prevalence of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in Saudi Arabian adults with chronic periodontitis. Medicine in Microecology. 2023;17:100086.35. Hyvärinen K, Laitinen S, Paju S, et al. Detection and quantification of five major periodontal pathogens by single copy gene-based real-time PCR. Innate Immunity. 2009;15(4):195-204.36. Kim J-H, Oh J-W, Lee Y, Yun J-H, Choi S-H, Lee D-W. Quantification of bacteria in mouth-rinsing solution for the diagnosis of periodontal disease.Journal of Clinical Medicine. 2021;10(4):891.37. Rubin LG. 181 - Other Gram-Negative Coccobacilli. In: Long SS, ed. Principles and Practice of Pediatric Infectious Diseases (Sixth Edition). Philadelphia: Elsevier; 2023:985-986.e981.38. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet. 2008;371(9608):237-242.39. Moraschini V, Calasans-Maia JA, Calasans-Maia MD. Association between asthma and periodontal disease: A systematic review and meta-analysis.J Periodontol. 2018;89(4):440-455.40. Belstrøm D, Fiehn NE, Nielsen CH, et al. Differences in bacterial saliva profile between periodontitis patients and a control cohort. J Clin Periodontol. 2014;41(2):104-112.41. Kanasi E, Dewhirst FE, Chalmers NI, et al. Clonal analysis of the microbiota of severe early childhood caries.Caries Res. 2010;44(5):485-497.42. Hsiao WW, Li KL, Liu Z, Jones C, Fraser-Liggett CM, Fouad AF. Microbial transformation from normal oral microbiota to acute endodontic infections. BMC Genomics. 2012;13:345.43. Siqueira JF, Jr., Rôças IN. Catonella morbi and Granulicatella adiacens: new species in endodontic infections.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(2):259-264.